| ACC | American College of Cardiology |
| ADA | American Diabetes Association |
| AHI | Apnea–hypopnea index |
| AHA | American Heart Association |
| ASCVD | Atherosclerotic cardiovascular disease |
| ASMR | Age-standardized mortality rate |
| BMD | Bone mineral density |
| BMI | Body mass index |
| BP | Blood pressure |
| CAD | Coronary artery disease |
| CVD | Cardiovascular disease |
| CKD | Chronic kidney disease |
| CRHM | Cardiovascular–Renal–Hepatic–Metabolic syndrome |
| DASH | Dietary approaches to stop hypertension |
| DPP4i | Dipeptidyl peptidase-4 inhibitors |
| EAPC | European Association of Preventive Cardiology |
| EASD | European Association for the Study of Diabetes |
| EASO | European Association for the Study of Obesity |
| ECG | Electrocardiogram |
| ESC | European Society of Cardiology |
| FHH | Functional hypogonadotropic hypogonadism |
| GDMT | Guideline-directed medical therapy |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GLP-1RA | Glucagon-like peptide-1 receptor agonist |
| HbA1c | Glycated hemoglobin |
| HF | Heart failure |
| HFpEF | Heart failure with preserved ejection fraction |
| HFrEF | Heart failure with reduced ejection fraction |
| HIF-1α | Hypoxia-inducible factor 1-alpha |
| HR | Hazard ratio |
| IGF-I | Insulin-like growth factor-I |
| LDL-C | Low-density lipoprotein cholesterol |
| MASLD | Metabolic dysfunction-associated steatotic liver disease |
| MHT | Menopausal hormone therapy |
| MHDS | Multiple hormonal and metabolic deficiency syndrome |
| NAFLD | Non-alcoholic fatty liver disease |
| NASH | Non-alcoholic steatohepatitis |
| NT-proBNP | N-terminal prohormone of brain natriuretic peptide |
| OSA | Obstructive sleep apnea |
| PAD | Peripheral artery disease |
| PCOS | Polycystic Ovary Syndrome |
| PCSK9 | Proprotein convertase subtilisin/kexin type 9 |
| PAP | Positive airway pressure |
| POI | Primary Ovarian Insufficiency |
| RCT | Randomized controlled trial |
| RMR | Resting metabolic rate |
| SGLT2i | Sodium-glucose cotransporter-2 inhibitors |
| siRNA | Small interfering RNA |
| T2DM | Type 2 diabetes mellitus |
| TTh | Testosterone therapy |
| TZD | Thiazolidinedione |
| VO2 max | Maximum oxygen consumption |